Down-regulation of HCP5 inhibits cell proliferation, migration, and invasion through regulating EPHA7 by competitively binding miR-101 in osteosarcoma

Patients with osteosarcoma (OS) usually have poor overall survival because of frequent metastasis. Long non-coding RNAs (lncRNAs) have been reported to be associated with tumorigenesis and metastasis. In this study, we investigated the expression and roles of lncRNA human histocompatibility leukocyt...

Full description

Bibliographic Details
Main Authors: Yangmao Tu, Qing Cai, Xuemei Zhu, Min Xu
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2021-01-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2021000200612&tlng=en
_version_ 1819008386931359744
author Yangmao Tu
Qing Cai
Xuemei Zhu
Min Xu
author_facet Yangmao Tu
Qing Cai
Xuemei Zhu
Min Xu
author_sort Yangmao Tu
collection DOAJ
description Patients with osteosarcoma (OS) usually have poor overall survival because of frequent metastasis. Long non-coding RNAs (lncRNAs) have been reported to be associated with tumorigenesis and metastasis. In this study, we investigated the expression and roles of lncRNA human histocompatibility leukocyte antigen (HLA) complex P5 (HCP5) in OS, aiming to provide a novel molecular mechanism for OS. HCP5 was up-regulated both in OS tissues and cell lines and high expression of HCP5 was associated to low survival in OS patients. Down-regulation of HCP5 inhibited cell proliferation, migration, and invasion, suggesting its carcinogenic role in OS. miR-101 was targeted by HCP5 and its expression was decreased in OS. The inhibitor of miR-101 reversed the impact of HCP5 down-regulation on cell proliferation, apoptosis, and metastasis in OS. Ephrin receptor 7 (EPHA7) was proved to be a target of miR-101 and had ability to recover the effects of miR-101 inhibitor in OS. In conclusion, lncRNA HCP5 knockdown suppressed cell proliferation, migration, and invasion, and induced apoptosis through depleting the expression of EPHA7 by binding to miR-101, providing a potential therapeutic strategy of HCP5 in OS.
first_indexed 2024-12-21T00:39:39Z
format Article
id doaj.art-10825bbbc2ca4bd0a8baf397f17d0f95
institution Directory Open Access Journal
issn 1414-431X
language English
last_indexed 2024-12-21T00:39:39Z
publishDate 2021-01-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-10825bbbc2ca4bd0a8baf397f17d0f952022-12-21T19:21:42ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research1414-431X2021-01-0154210.1590/1414-431x20209161Down-regulation of HCP5 inhibits cell proliferation, migration, and invasion through regulating EPHA7 by competitively binding miR-101 in osteosarcomaYangmao Tuhttps://orcid.org/0000-0003-3289-5083Qing Caihttps://orcid.org/0000-0003-2905-2368Xuemei Zhuhttps://orcid.org/0000-0001-6181-8998Min Xuhttps://orcid.org/0000-0001-9556-1596Patients with osteosarcoma (OS) usually have poor overall survival because of frequent metastasis. Long non-coding RNAs (lncRNAs) have been reported to be associated with tumorigenesis and metastasis. In this study, we investigated the expression and roles of lncRNA human histocompatibility leukocyte antigen (HLA) complex P5 (HCP5) in OS, aiming to provide a novel molecular mechanism for OS. HCP5 was up-regulated both in OS tissues and cell lines and high expression of HCP5 was associated to low survival in OS patients. Down-regulation of HCP5 inhibited cell proliferation, migration, and invasion, suggesting its carcinogenic role in OS. miR-101 was targeted by HCP5 and its expression was decreased in OS. The inhibitor of miR-101 reversed the impact of HCP5 down-regulation on cell proliferation, apoptosis, and metastasis in OS. Ephrin receptor 7 (EPHA7) was proved to be a target of miR-101 and had ability to recover the effects of miR-101 inhibitor in OS. In conclusion, lncRNA HCP5 knockdown suppressed cell proliferation, migration, and invasion, and induced apoptosis through depleting the expression of EPHA7 by binding to miR-101, providing a potential therapeutic strategy of HCP5 in OS.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2021000200612&tlng=enlncRNA HCP5OsteosarcomamiR-101EPHA7
spellingShingle Yangmao Tu
Qing Cai
Xuemei Zhu
Min Xu
Down-regulation of HCP5 inhibits cell proliferation, migration, and invasion through regulating EPHA7 by competitively binding miR-101 in osteosarcoma
Brazilian Journal of Medical and Biological Research
lncRNA HCP5
Osteosarcoma
miR-101
EPHA7
title Down-regulation of HCP5 inhibits cell proliferation, migration, and invasion through regulating EPHA7 by competitively binding miR-101 in osteosarcoma
title_full Down-regulation of HCP5 inhibits cell proliferation, migration, and invasion through regulating EPHA7 by competitively binding miR-101 in osteosarcoma
title_fullStr Down-regulation of HCP5 inhibits cell proliferation, migration, and invasion through regulating EPHA7 by competitively binding miR-101 in osteosarcoma
title_full_unstemmed Down-regulation of HCP5 inhibits cell proliferation, migration, and invasion through regulating EPHA7 by competitively binding miR-101 in osteosarcoma
title_short Down-regulation of HCP5 inhibits cell proliferation, migration, and invasion through regulating EPHA7 by competitively binding miR-101 in osteosarcoma
title_sort down regulation of hcp5 inhibits cell proliferation migration and invasion through regulating epha7 by competitively binding mir 101 in osteosarcoma
topic lncRNA HCP5
Osteosarcoma
miR-101
EPHA7
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2021000200612&tlng=en
work_keys_str_mv AT yangmaotu downregulationofhcp5inhibitscellproliferationmigrationandinvasionthroughregulatingepha7bycompetitivelybindingmir101inosteosarcoma
AT qingcai downregulationofhcp5inhibitscellproliferationmigrationandinvasionthroughregulatingepha7bycompetitivelybindingmir101inosteosarcoma
AT xuemeizhu downregulationofhcp5inhibitscellproliferationmigrationandinvasionthroughregulatingepha7bycompetitivelybindingmir101inosteosarcoma
AT minxu downregulationofhcp5inhibitscellproliferationmigrationandinvasionthroughregulatingepha7bycompetitivelybindingmir101inosteosarcoma